TONABACASE
UNII 6F1Q7D668G

Substance Identification & Data

This profile provides standardized clinical and technical data for Tonabacase, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6F1Q7D668G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1788041-31-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
6F1Q7D668G
CAS Registry Number
1788041-31-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TONABACASE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10357
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tonabacase. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TONABACASE

Common Names & Synonyms

STAPHYLOCOCCUS AUREUS PHAGE 1 (SAP-1)-DERIVED SOLUBLE ENDOLYSIN (STAPHYLOCOCCUS AUREUS PHAGE LYSIN-1, BACTERIOLYSIN SAL-1)
TONABACASE [INN]
TONABACASE [WHO-DD]

Systematic Nomenclature

BACTERIOLYSIN SAL-1 (STAPHYLOCOCCUS PHAGE SAP-1)